Precision Medicine

Understanding the role lymphoid structures in metastatic colorectal cancer may provide new treatment options

A clinical trial that evaluates the approach for medulloblastoma, the most common malignant pediatric brain tumor, is planned

Thanks to a global community of researchers, the first draft of the human proteome is complete

A fully automated approach to -omics analysis is improving outcomes for a range of diseases

Agreements with AstraZeneca and the University of Nebraska Medical Center showcase new workflows to improve the throughput, robustness and standardization of clinical biomarker analysis

Clinical trial of selpercatinib shows strong response for patients with non-small cell lung cancer

System predicts tumor response to different treatments

Trial provides the strongest evidence yet that simple blood tests known as liquid biopsies can benefit women with breast cancer by tracking their disease as it evolves

Share your thoughts on the challenges and future potential of precision medicine

Join Clinical Lab Manager and our panel of experts as we discuss how clinical mass spectrometry is advancing the transition from detecting illness to quantifying wellness